Basit öğe kaydını göster

dc.contributor.authorBaşaranoğlu, Metin
dc.contributor.authorCanbakan, Billur
dc.contributor.authorYıldız, Kemal
dc.contributor.authorCeylan, Bahadır
dc.contributor.authorBaysal, Birol
dc.contributor.authorUysal, Ömer
dc.contributor.authorŞentürk, Hakan
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T20:03:44Z
dc.date.available10.07.201910:49:13
dc.date.available2019-07-10T20:03:44Z
dc.date.issued2014en_US
dc.identifier.citationBaşaranoğlu, M., Canbakan, B., Yıldız, K., Ceylan, B., Baysal, B., Uysal, Ö. ... Şentürk, H. (2014). Fatty liver disease might increase the risk of abdominal operation in patients with fatty liver and the prevalence of cancer in first-degree relatives. Turkish Journal of Gastroenterology, 25(Supplement: 1), 138-141. https://dx.doi.org/10.5152/tjg.2014.7674en_US
dc.identifier.issn1300-4948
dc.identifier.issn2148-5607
dc.identifier.urihttps://dx.doi.org/10.5152/tjg.2014.7674
dc.identifier.urihttps://hdl.handle.net/20.500.12511/3932
dc.description63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Disease (AASLD) -- NOV 09-13, 2012 -- Boston, MAen_US
dc.descriptionWOS: 000353553700026en_US
dc.descriptionPubMed ID: 25910292en_US
dc.description.abstractBackground/Aims: We investigated the risk of abdominal operation in patients with fatty liver and the risk of any cancer in first-degree relatives of patients with fatty liver. Materials and Methods: We evaluated 105 patients with nonalcoholic fatty liver disease (NAFLD), 121 patients with biopsy-proven hepatitis C (61 patients with fatty liver and 60 patients without fatty liver), 50 patients with inflammatory bowel disease (IBD), and 109 patients with dyspepsia. Results: There was no difference in sex, mean age, and marital status among the groups except that patients with IBD were younger than the others (p<0.001). The frequency of cancer among family members was 18% in IBD, 9% in dyspepsia, 28% in hepatitis C with steatosis, 21.5% in hepatitis C without steatosis, and 27% in NAFLD (p=0.006). Then, we divided the study group into two groups as follows: group 1: (IBD + dyspepsia + hepatitis C without steatosis) and group 2: (hepatitis C with steatosis + NAFLD). We found that the frequency of cancer was 16% in group 1 versus 24.4 % in group 2 (p=0.037). We also investigated the risk of abdominal operation in patients with fatty liver. The results were as follows: 33% in group without fatty liver versus 43% in group with fatty liver (p=0.043). Conclusion: Understanding the underlying causes of fatty liver forms might decrease the cancer frequency in the population and number of operations in patients with fatty liver.en_US
dc.description.sponsorshipAmerican Association for the Study of Liver Diseasesen_US
dc.language.isoengen_US
dc.publisherAVESen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAbdominal Operationen_US
dc.subjectCanceren_US
dc.subjectDyspepsiaen_US
dc.subjectFatty Liveren_US
dc.subjectHepatitis Cen_US
dc.subjectNonalcoholicen_US
dc.titleFatty liver disease might increase the risk of abdominal operation in patients with fatty liver and the prevalence of cancer in first-degree relativesen_US
dc.typearticleen_US
dc.relation.ispartofTurkish Journal of Gastroenterologyen_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Ana Bilim Dalıen_US
dc.authorid0000-0001-9658-7560en_US
dc.identifier.volume25en_US
dc.identifier.issueSupplement: 1en_US
dc.identifier.startpage138en_US
dc.identifier.endpage141en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.5152/tjg.2014.7674en_US
dc.identifier.wosqualityQ4en_US
dc.identifier.scopusqualityQ3en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster